(April 26 21:30) Forbes.com
Revenues expected to be slightly above the consensus estimates Trefis estimates Boston Scientific’s Q1 2022 revenues to be around $3.0 billion, slightly above the $2.9 billion consensus estimate.
You can find the original article
here